Stephen C. Harrison
17Patents
1h-index
25Co-inventors
54Inventor score
Filing activity: Mar 8, 2000 → Apr 27, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6551597B1 | Vaccine compositions for human papillomavirus | Physics | 8 | Expired |
| US8685411B2 | Rotavirus antigens | Chemistry; Metallurgy | 1 | Active |
| US7524624B2 | Druggable regions in the dengue virus envelope glycoprotein and methods of using the same | Physics | 1 | Expired |
| US10192025B2 | Rotavirus particles with chimeric surface proteins | Chemistry; Metallurgy | 0 | Active |
| US10092638B2 | GP120 immunogens and methods inducing neutralizing antibodies to human immunodeficiency virus | Emerging Cross-Sectional Technologies | 0 | Active |
| US9718873B2 | Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin | Chemistry; Metallurgy | 0 | Active |
| US10835599B2 | Methods to identify prime and boost immunogens for use in a B cell lineage-based vaccination protocol | Emerging Cross-Sectional Technologies | 0 | Active |
| US9707289B2 | Biochemically stabilized HIV-1 ENV trimer vaccine | Chemistry; Metallurgy | 0 | Active |
| US9950060B2 | Biochemically stabilized HIV-1 Env trimer vaccine | Chemistry; Metallurgy | 0 | Active |
| US10307478B2 | Biochemically stabilized HIV-1 Env trimer vaccine | Chemistry; Metallurgy | 0 | Active |
| US8741310B2 | Fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies | Chemistry; Metallurgy | 0 | Active |
| US11229696B2 | Biochemically stabilized HIV-1 Env trimer vaccine | Chemistry; Metallurgy | 0 | Active |
| US10653770B2 | Biochemically stabilized HIV-1 Env trimer vaccine | Chemistry; Metallurgy | 0 | Active |
| US8673552B2 | Druggable regions in the dengue virus envelope glycoprotein and methods of using the same | Physics | 0 | Active |
| US11053285B2 | Nucleic acids encoding human immunodeficiency virus type 1 (HIV-1) N-terminal deleted gp120 immunogens and methods of use | Chemistry; Metallurgy | 0 | Active |
| US10040826B2 | Human immunodeficiency virus type 1 (HIV-1) N-terminal deleted GP120 immunogens | Chemistry; Metallurgy | 0 | Active |
| US10463729B2 | Biochemically stabilized HIV-1 env trimer vaccine | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.